Ardent Health (NYSE:ARDT) Posts Earnings Results, Beats Expectations By $0.10 EPS

Ardent Health (NYSE:ARDT) announced its quarterly earnings results on Tuesday. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10, Zacks reports. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health had a net margin of 2.15% and a return on equity of 14.30%. Ardent Health updated its FY 2026 guidance to 0.900-1.270 EPS.

Ardent Health Stock Down 3.0%

ARDT stock traded down $0.30 during midday trading on Wednesday, hitting $9.83. The company’s stock had a trading volume of 91,722 shares, compared to its average volume of 389,730. The company has a quick ratio of 1.85, a current ratio of 1.97 and a debt-to-equity ratio of 0.64. Ardent Health has a 52-week low of $8.07 and a 52-week high of $15.48. The firm has a market capitalization of $1.41 billion, a P/E ratio of 10.24 and a beta of 0.93. The firm has a 50-day simple moving average of $9.26 and a 200-day simple moving average of $9.82.

Hedge Funds Weigh In On Ardent Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ARDT. Caitong International Asset Management Co. Ltd boosted its position in Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after buying an additional 2,638 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Ardent Health in the 3rd quarter valued at approximately $61,000. New York State Common Retirement Fund boosted its position in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after buying an additional 3,400 shares during the period. Squarepoint Ops LLC purchased a new position in Ardent Health in the 3rd quarter valued at approximately $145,000. Finally, Fox Run Management L.L.C. purchased a new position in Ardent Health in the 4th quarter valued at approximately $147,000.

Wall Street Analyst Weigh In

Several analysts recently weighed in on ARDT shares. Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Leerink Partners dropped their target price on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a report on Friday, March 6th. JPMorgan Chase & Co. dropped their target price on shares of Ardent Health from $12.00 to $11.00 and set a “neutral” rating for the company in a report on Tuesday, January 20th. Finally, Royal Bank Of Canada dropped their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, March 9th. Seven equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Ardent Health presently has a consensus rating of “Hold” and a consensus price target of $14.25.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.